Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Reclassifying wine intake reshapes the Mediterranean diet’s cognitive impact

17

Nov 2025

Reclassifying wine intake reshapes the Mediterranean diet’s cognitive impact

Higher adherence to the Mediterranean diet was not associated with better cognition when wine was scored as a “beneficial” component. When wine was reverse scored, Mediterranean diet adherence showed a modest positive association with MMSE performance and a borderline link with MoCA in Portuguese older adults at high dementia risk.

Study: PTSD treatment dropout rates vary widely

17

Nov 2025

Study: PTSD treatment dropout rates vary widely

About a quarter of U.S. service members and veterans who start psychotherapy for post-traumatic stress disorder quit before they finish treatment. But not all therapies are equal in their appeal, with some effective approaches reporting the highest dropout rates, according to research published by the American Psychological Association.

Calculator assesses 30-year heart risk for young adults

17

Nov 2025

Calculator assesses 30-year heart risk for young adults

Just as saving for retirement starts early, so should protecting your heart. A new Northwestern Medicine study introduces a first-of-its-kind online calculator that uses percentiles to help younger adults forecast and understand their risk of a heart event over the next 30 years.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.